CBA
SPRY icon

Coastal Bridge Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Coastal Bridge Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$448K Buy
55,730
+1,900
+4% +$18.2K 0.03% 328
2025
Q4 		$627K Sell
53,830
-37,845
-41% -$368K 0.05% 279
2025
Q3 		$921K Buy
91,675
+4,650
+5% +$66.7K 0.07% 218
2025
Q2 		$1.52M Buy
87,025
+40,275
+86% +$581K 0.13% 164
2025
Q1 		$588K Buy
+46,750
New +$562K 0.15% 151

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Coastal Bridge Advisors's SPRY Position: Q1 2026 in Review

Coastal Bridge Advisors increased its ARS Pharmaceuticals (SPRY) stake by 3.5% in Q1 2026, buying an estimated $18.2K and bringing the position to 55,730 shares worth $448K. The position accounts for 0.03% of the portfolio, ranked #328.

Coastal Bridge Advisors first reported a position in SPRY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.52M in Q2 2025. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • Coastal Bridge Advisors held 55,730 shares of ARS Pharmaceuticals worth $448K as of Q1 2026.
  • Coastal Bridge Advisors bought 1,900 ARS Pharmaceuticals shares in Q1 2026, an estimated $18.2K.
  • ARS Pharmaceuticals made up 0.03% of Coastal Bridge Advisors's portfolio in Q1 2026, its #328 holding.
  • Coastal Bridge Advisors first reported a position in ARS Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Coastal Bridge Advisors's ARS Pharmaceuticals position peaked at $1.52M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Coastal Bridge Advisors's 13F filing for Q1 2026, filed 14 May 2026.